Platelet aggregation and antithrombin III levels in diabetic children

Area of Science:

• Pediatric Endocrinology
• Hematology
• Vascular Biology

Background:

• Insulin-dependent diabetes mellitus (IDDM) in children can lead to microvascular complications.
• Platelet function and coagulation factors are often altered in diabetes.
• Early detection of vascular risk in pediatric diabetes is crucial.

Purpose of the Study:

• To investigate platelet function and antithrombin III levels in children with IDDM.
• To determine if subclinical microvascular changes are present in these patients.
• To explore potential early markers of altered hemostasis in pediatric diabetes.

Main Methods:

• Compared 30 children with IDDM (no clinical vascular complications) to 25 healthy controls.
• Assessed template bleeding time and ADP/adrenaline-induced platelet aggregation.
• Measured plasma antithrombin III levels and antiheparin activity (platelet factor 4).

Main Results:

• No significant differences were found in bleeding time or platelet aggregation thresholds between groups.
• Plasma antithrombin III levels were significantly higher in the diabetic children.
• Platelet factor 4 levels did not differ between diabetic children and controls.

Conclusions:

• Children with IDDM, even without clinical vascular complications, do not exhibit laboratory evidence of increased platelet activity.
• Elevated antithrombin III levels in diabetic children may indicate an early compensatory response against hypercoagulability.
• Further research is needed to understand the long-term implications of these findings in pediatric diabetes management.